Literature DB >> 12889995

Expression and function of HLA-DR3 and DQ8 in transgenic mice lacking functional H2-M.

G Rajagopalan1, M K Smart, S Cheng, C J Krco, K L Johnson, C S David.   

Abstract

H2-M or HLA-DM are non-classical class II molecules encoded by the MHC and play an important role during antigen presentation. They catalyze exchange of CLIP (Class II-associated invariant chain peptide) or other low-affinity peptides bound to class II molecules for peptides capable of more efficient binding. The phenotype of mice lacking H2-M is determined by the allotype of the MHC class II molecules expressed. In general, H2-M deficiency does not affect the surface expression of mature class II molecules. The class II molecules in such cases predominantly contain CLIP in their peptide-binding groove. In some mice strains, H2-M deficiency results in defective CD4+ T-cell development accompanied by defective responses to conventional antigens and superantigens. Even though the HLA class II molecules show similar dependency for HLA-DM for presenting antigens in vitro, their interaction in vivo is not known. By using transgenic approach we show here that DQ8 and DR3 are expressed at normal levels in H2-M-deficient mice and the CD4+ T-cell development is unaltered. However, the ability of DQ8 molecules to present peptide antigens is compromised in a H2-M-deficient state. Presentation of exogenous bacterial superantigens by both DQ8 and DR3 is unaffected in H2-M-deficient mice. Unexpectedly, Staphylococcal Enterotoxin B-induced systemic IFN-gamma production was significantly higher in H2-M-deficient DQ8/DR3 transgenic mice and these mice were susceptible to SEB-induced toxic shock at doses that are non-lethal to H2-M-sufficient counterparts.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12889995     DOI: 10.1034/j.1399-0039.2003.00088.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  15 in total

1.  Endogenous superantigens shape response to exogenous superantigens.

Authors:  Govindarajan Rajagopalan; Manisha Singh; Moon M Sen; Narayana S Murali; Karl A Nath; Chella S David
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

2.  In vitro and in vivo evaluation of staphylococcal superantigen peptide antagonists.

Authors:  Govindarajan Rajagopalan; Moon M Sen; Chella S David
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

3.  Early gene expression changes induced by the bacterial superantigen staphylococcal enterotoxin B and its modulation by a proteasome inhibitor.

Authors:  Govindarajan Rajagopalan; Ashenafi Y Tilahun; Yan W Asmann; Chella S David
Journal:  Physiol Genomics       Date:  2009-03-31       Impact factor: 3.107

4.  Superantigens produced by catheter-associated Staphylococcus aureus elicit systemic inflammatory disease in the absence of bacteremia.

Authors:  Jin-Won Chung; Kerryl E Greenwood-Quaintance; Melissa J Karau; Ashenafi Tilahun; Shahryar Rostamkolaei Khaleghi; Vaidehi R Chowdhary; Chella S David; Robin Patel; Govindarajan Rajagopalan
Journal:  J Leukoc Biol       Date:  2015-05-15       Impact factor: 4.962

5.  Generation, characterization, and epitope mapping of neutralizing and protective monoclonal antibodies against staphylococcal enterotoxin B-induced lethal shock.

Authors:  Avanish K Varshney; Xiaobo Wang; Emily Cook; Kaushik Dutta; Matthew D Scharff; Michael J Goger; Bettina C Fries
Journal:  J Biol Chem       Date:  2011-01-13       Impact factor: 5.157

6.  Human leukocyte antigen class II transgenic mouse model unmasks the significant extrahepatic pathology in toxic shock syndrome.

Authors:  Ashenafi Y Tilahun; Eric V Marietta; Tsung-Teh Wu; Robin Patel; Chella S David; Govindarajan Rajagopalan
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

7.  Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice.

Authors:  Govindarajan Rajagopalan; Koji Iijima; Manisha Singh; Hirohito Kita; Robin Patel; Chella S David
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

8.  Superantigen profiling of Staphylococcus aureus infective endocarditis isolates.

Authors:  Jin-Won Chung; Melissa J Karau; Kerryl E Greenwood-Quaintance; Alessandro D Ballard; Ashenafi Tilahun; Shahryar Rostamkolaei Khaleghi; Chella S David; Robin Patel; Govindarajan Rajagopalan
Journal:  Diagn Microbiol Infect Dis       Date:  2014-03-17       Impact factor: 2.803

9.  Measurement of staphylococcal enterotoxin B in serum and culture supernatant with a capture enzyme-linked immunosorbent assay.

Authors:  E Cook; X Wang; N Robiou; B C Fries
Journal:  Clin Vaccine Immunol       Date:  2007-07-18

10.  Chronic exposure to staphylococcal superantigen elicits a systemic inflammatory disease mimicking lupus.

Authors:  Vaidehi R Chowdhary; Ashenafi Y Tilahun; Chad R Clark; Joseph P Grande; Govindarajan Rajagopalan
Journal:  J Immunol       Date:  2012-07-13       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.